Highlights Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Delayed London S.E. Other stock markets 12:41:21 13/05/2024 pm IST			5-day change	1st Jan Change
39.95 ^GBX	+2.44%		+6.53%	-3.73%

30/04	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
30/04	Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	01/05	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	30/04	CI
Beximco Pharmaceuticals to strengthen portfolio as interim profit up	30/01	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2023	30/01	CI
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	30/01	CI
Ex-dividend day for final dividend	14/11	FA
Beximco Pharmaceuticals Posts Higher Fiscal Q1 Profit, Revenue	06/11	MT
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	06/11	CI
Beximco boosts revenue in local currency but profit falls	01/11	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	01/11	CI
Beximco Pharmaceuticals Limited Proposes Dividend for the Year Ended June 30, 2023	20/23/20	CI
Beximco Pharmaceuticals to Tackle Ophthalmic Manufacturing Unit Deficiencies After Malta Medicines Authority Audit	11/23/11	MT
EARNINGS UPDATES: HC Slingsby profit falls, East Imperial loss narrows	02/23/02	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	02/23/02	CI
TRADING UPDATES: Ferro-Alloy eyes revenue to drop below market view	30/23/30	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	30/23/30	CI
Beximco Pharmaceuticals Limited Announces Cash Dividend for the Year Ended June 30, 2022	19/23/19	CI
Ex-dividend day for final dividend	22/22/22	FA
EARNINGS SUMMARY: Goodbody shifts away from Covid; Beximco profit down	11/22/11	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	11/22/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Highlights

Filters